NF-κB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells
NF-κB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells
复制标题
DOI:
10.1002/pros.20376
复制
发表时间:
2006-08-01
期刊:
影响因子:
2.8
通讯作者:
Leung, Hing Y.
中科院分区:
文献类型:
--
作者:
Armstrong, Kelly;Robson, Craig N.;Leung, Hing Y.
BACKGROUND. Fibroblast growth factor 8 (FGF8) is over-expressed in prostate cancer (CaP) correlating with high-grade disease and reduced survival. The role of acetylation in transcriptional regulation of FGF8 was investigated using the histone deacetylase (HDAC) inhibitor Trichostatin A (TSA).METHODS. FGF8 transcriptional response to TSA was investigated by gene reporter assays, RT-PCR, and Western blotting. Chromatin immunoprecipitation (ChIP) assays were also performed.RESULTS. FGF8 is upregulated in response to TSA treatment along with NF-kappa B transcriptional activity. Over-expression of p65 activated FGF8 transcription. ChIP assays revealed p65 recruitment to the fgf8 promoter, containing putative NF-kappa B binding sites, post TSA stimulation. PI-3K activity is required for TSA mediated FGF8 upregulation.CONCLUSION. Using TSA treatment in prostate cancer cells, a requirement of PI-3K activity in mediating TSA function is demonstrated and a novel role for NF-kappa B in the regulation of FGF8 expression is uncovered.